Difluoromethylornithine in cancer: new advances

作者:Alexiou George A*; Lianos Georgios D; Ragos Vassileios; Galani Vasiliki; Kyritsis Athanassios P
来源:Future Oncology, 2017, 13(9): 809-819.
DOI:10.2217/fon-2016-0266

摘要

Difluoromethylornithine (DFMO; eflornithine) is an irreversible suicide inhibitor of the enzyme ornithine decarboxylase which is involved in polyamine synthesis. Polyamines are important for cell survival, thus DFMO was studied as an anticancer agent and as a chemoprevention agent. DFMO exhibited mainly cytostatic activity and had single agent efficacy as well as activity in combination with other chemotherapeutic drugs for some cancers and leukemias. Herewith, we summarize the current knowledge of the anticancer and chemopreventive properties of DFMO and assess the status of clinical trials.

  • 出版日期2017-4